Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, et al. PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma. Nat Cancer. 2023;4:1508-1525 pubmed publisher

Kol I, Rishiq A, Cohen M, Kahlon S, Pick O, Dassa L, et al. CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. J Cell Biol. 2023;222: pubmed publisher

Wei W, Geer M, Guo X, Dolgalev I, Sanjana N, Neel B. Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition. J Exp Med. 2023;220: pubmed publisher

Park M, Kim S, Lee C. DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening. J Enzyme Inhib Med Chem. 2023;38:309-318 pubmed publisher

Koester A, Tao K, Szczepaniak M, Rames M, Nan X. Nanoscopic Spatial Association between Ras and Phosphatidylserine on the Cell Membrane Studied with Multicolor Super Resolution Microscopy. Biomolecules. 2022;12: pubmed publisher

Yim J, Park S. Label-Free Target Identification Reveals the Anticancer Mechanism of a Rhenium Isonitrile Complex. Front Chem. 2022;10:850638 pubmed publisher

Xu J, Xu K, Jung S, Conte A, Lieberman J, Muecksch F, et al. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021;595:278-282 pubmed publisher